Physician

Fabrizio Monge, M.D.

According to 2025 Medicare claims, Fabrizio Monge, M.D. (NPI: 1972605434) practices pulmonary disease in the Punta Gorda, FL market, with the plurality of this provider's patient population coming from Charlotte, FL. This provider's primary affiliated billing organization is PULMONARY SLEEP AND CRITICAL CARE SPECIALISTS PL (NPI: 1215367115; TIN: 46-4075197) and primary practice location at 33980-8421.

Monge's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 1,840 traditional Medicare patients, billed 5,838 HCPCS/CPT codes, and received $565,355 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,070 prescription claims across 492 beneficiaries totaling $1,665,637 in drug costs, led by Trelegy Ellipta (Fluticasone/Umeclidin/Vilanter). DME data shows 10,823 claims. Open Payments data shows 115 records totaling $2,307. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has changed little. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $866,707 to $1,665,637. For DME billing, reported payments changed little.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	2,067	6,854	$622,238
2016	2,111	7,128	$660,348
2017	2,009	6,271	$605,930
2018	2,104	6,386	$628,454
2019	2,070	6,532	$637,076
2020	1,933	6,380	$574,091
2021	2,009	7,804	$710,317
2022	1,817	6,537	$563,456
2023	1,831	6,664	$626,834
2024	1,840	5,838	$565,355

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	438	2,036	$866,707
2016	466	2,321	$882,843
2017	485	2,414	$1,205,405
2018	554	2,461	$1,420,057
2019	563	2,513	$1,523,214
2020	534	2,575	$1,902,209
2021	466	2,224	$1,624,809
2022	435	1,852	$1,346,464
2023	445	1,917	$1,731,796
2024	492	2,070	$1,665,637

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	3,345	9,270	$678,311
2016	3,982	10,325	$581,602
2017	4,244	11,340	$518,047
2018	4,700	12,750	$641,223
2019	4,874	13,666	$746,021
2020	4,546	12,813	$701,708
2021	4,193	11,499	$670,910
2022	3,940	10,366	$594,388
2023	3,759	10,016	$597,519
2024	3,865	10,823	$586,772

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	804	1,401	$97
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	320	371	$67
94729	Test to examine how well the lungs exchange gases	424	450	$43
94727	Test to determine lung volumes using gas dilution or washout	424	450	$34
94010	Test to measure expiratory airflow and volume	278	289	$21

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Trelegy Ellipta	Fluticasone/Umeclidin/Vilanter	559	32,700	$682,419
Ofev	Nintedanib Esylate	39	1,155	$505,405
Breztri Aerosphere	Budesonide/Glycopyr/Formoterol	201	10,020	$204,010
Breo Ellipta	Fluticasone/Vilanterol	115	6,780	$88,255
Anoro Ellipta	Umeclidinium Brm/Vilanterol Tr	75	4,620	$69,994

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A7031	Face mask interface, replacement for full face mask, each	N	231	662	$58,916
E0470	Respiratory assist device, bi-level pressure capability, without backup rate feature, used with noninvasive interface, e.g., nasal or facial mask (intermittent assist device with continuous positive airway pressure device)	Y	115	690	$56,766
A7030	Full face mask used with positive airway pressure device, each	N	243	632	$52,866
E1390	Oxygen concentrator, single delivery port, capable of delivering 85 percent or greater oxygen concentration at the prescribed flow rate	Y	78	613	$46,706
A7032	Cushion for use on nasal mask interface, replacement only, each	N	196	476	$46,149

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	115	$2,307	AstraZeneca Pharmaceuticals LP
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Fabrizio Monge, M.D.?

Tedicare shows public-source Medicare data for Fabrizio Monge, M.D. (NPI 1972605434), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Fabrizio Monge, M.D. have ACO affiliation data?

No ACO affiliation record is shown in the available Tedicare data for this profile.

What billing organization is linked to Fabrizio Monge, M.D.?

Fabrizio Monge, M.D. is linked to PULMONARY SLEEP AND CRITICAL CARE SPECIALISTS PL (billing NPI 1215367115) in the available physician profile data.

Does Fabrizio Monge, M.D. have Open Payments data?

Fabrizio Monge, M.D. has 115 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.